These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10712830)

  • 1. INFLUENCE OF BASELINE VALUES ON LIPIDS, LIPOPROTEINS AND FIBRINOLYTIC PARAMETERS DURING TREATMENT OF HYPERTENSION WITH CILNIDIPINE.
    Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
    Pharmacol Res; 2000 Jan; 41(1):79-82. PubMed ID: 10712830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during treatment of hypertension with cilnidipine.
    Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
    Pharmacol Res; 2000 Jan; 41(1):81-4. PubMed ID: 10600273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INFLUENCE OF BASELINE VALUES ON LIPIDS, LIPOPROTEINS AND FIBRINOLYTIC PARAMETERS DURING AMLODIPINE TREATMENT OF HYPERTENSION IN JAPANESE PATIENTS.
    Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
    Pharmacol Res; 2000 Jan; 41(1):73-77. PubMed ID: 10712829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients.
    Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
    Pharmacol Res; 2000 Jan; 41(1):75-9. PubMed ID: 10600272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cilnidipine on lipids, lipoproteins and fibrinolytic system in hypertensive patients.
    Ahaneku JE; Sakata K; Uranol T; Takada Y; Takada A
    Drugs Exp Clin Res; 2000; 26(4):119-23. PubMed ID: 11109511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of baseline values. II: Variations in plasma lipoprotein fractions during doxazosin treatment for hypertension.
    Ahaneku JE; Taylor GO; Agbedana EO
    Int J Clin Pharmacol Res; 1998; 18(4):165-70. PubMed ID: 10052026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of baseline values on lipids and lipoprotein changes during amlodipine treatment of hypertension.
    Ahaneku JE
    Pharmacol Res; 1998 Sep; 38(3):179-82. PubMed ID: 9782067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid and lipoprotein profile in physiological pregnancy.
    Lippi G; Albiero A; Montagnana M; Salvagno GL; Scevarolli S; Franchi M; Guidi GC
    Clin Lab; 2007; 53(3-4):173-7. PubMed ID: 17447654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of baseline values. I: Effects on plasma total cholesterol and triglyceride levels during doxazosin treatment for hypertension.
    Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
    Int J Clin Pharmacol Res; 1998; 18(4):159-63. PubMed ID: 10052025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observed changes in the lipid profile and calculated coronary risk in patients given dietary advice in primary care.
    Price D; Ramachandran S; Knight T; Jones PW; Neary RH
    Br J Gen Pract; 2000 Sep; 50(458):712-5. PubMed ID: 11050787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study.
    Urquizu-Padilla M; Balada E; Chacon P; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 Aug; 36(8):1639-45. PubMed ID: 19531751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.
    Nguyen NT; Varela E; Sabio A; Tran CL; Stamos M; Wilson SE
    J Am Coll Surg; 2006 Jul; 203(1):24-9. PubMed ID: 16798484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT; Anderson JL; Pearson RR; Jensen JR; Horne BD; Lavasani F; Yannicelli HD; Muhlestein JB
    Am J Cardiol; 2008 Feb; 101(4):486-9. PubMed ID: 18312763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.